Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Desloratadine in Colitis, Ulcerative: NCT07333716 Clinical Landscape Report 2026
16 October 2026
NCT07333716 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sintilimab in Hepatocellular Carcinoma: NCT07331883 Clinical Landscape Report 2026
16 October 2026
NCT07331883 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Acetaminophen in Multiple Hamartoma Syndrome: NCT07337902 Clinical Landscape Report 2026
16 October 2026
NCT07337902 clinical landscape for Multiple Hamartoma Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Icaritin in Hepatocellular Carcinoma: NCT07337460 Clinical Landscape Report 2026
16 October 2026
NCT07337460 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Leucovorin Calcium in Hepatocellular Carcinoma: NCT07337421 Clinical Landscape Report 2026
16 October 2026
NCT07337421 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Serplulimab in Pancreatic Ductal Adenocarcinoma: NCT07336953 Clinical Landscape Report 2026
16 October 2026
NCT07336953 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
A-CAR032 in Metastatic castration-resistant prostate cancer: NCT07344311 Clinical Landscape Report 2026
16 October 2026
NCT07344311 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
Vancomycin Hydrochloride in Cholangitis, Sclerosing: NCT07341282 Clinical Landscape Report 2026
16 October 2026
NCT07341282 clinical landscape for Cholangitis, Sclerosing: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DZ-002 in Adenocarcinoma: NCT07344220 Clinical Landscape Report 2026
16 October 2026
NCT07344220 clinical landscape for Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cetuximab in Pancreatic Ductal Adenocarcinoma: NCT07349537 Clinical Landscape Report 2026
16 October 2026
NCT07349537 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
RSS-0343 in Pulmonary Disease, Chronic Obstructive: NCT07349524 Clinical Landscape Report 2026
16 October 2026
NCT07349524 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
IBI-363 in Pancreatic Cancer: NCT07342725 Clinical Landscape Report 2026
16 October 2026
NCT07342725 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.